COMP <GO>
APH vs NVDA // REVENUE GROWTH (YOY)
Amphenol Corporation (NYSE) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: APH 4
— NVDA 11
▲ REVENUE GROWTH (YOY) LEADER: NVDA
LAST: $79.30 (-3.39%) • MKT CAP: $202.41B
revenue-growth
51.70%
LAST: $204.64 (-4.22%) • MKT CAP: $4.93T
revenue-growth
83.38%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APH VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APH | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.90% | 74.67% | -37.77 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.60% | 65.06% | -36.46 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.9x | 23.2x | +6.69 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 2.16% | 2.58% | -0.42 | NVDA | /fcf-yield <GO> |
| Operating Margin | 25.40% | 65.21% | -39.81 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 18.50% | 63.66% | -45.16 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 51.70% | 83.38% | -31.68 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.40% | 0.02% | +0.38 | APH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.34 | 19.52 | -12.18 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | APH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.70% | 9.01% | -1.31 | APH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.8 | 35.1 | +11.71 | APH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.23 | 2.04 | -0.81 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.8x | 17.0x | +22.78 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $202.41B | $4.93T | -$4.73T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APH REV | NVDA REV | APH GROSS % | NVDA GROSS % | APH FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $23.09B | $130.50B | 36.9% | 75.0% | $4.38B | $60.85B |
| FY 2024 | $15.22B | $60.92B | 33.8% | 72.7% | $2.15B | $27.02B |
| FY 2023 | $12.55B | $26.97B | 44.0% | 56.9% | $1.96B | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APH // BETA 1.23
NVDA // BETA 2.04